CHAPEL HILL, N.C.--(BUSINESS WIRE)--Feb. 18, 2005--POZEN Inc.
(NASDAQ: POZN), announced today it will host a conference call
following the release of financial results for the fourth quarter and
full-year 2004. The company will release results before the market
opens on Monday, February 28, 2005. John R. Plachetka, Pharm.D.,
POZEN's chairman, president and chief executive officer, and William
L. Hodges, chief financial officer, will host the conference call the
same day at 11:00 a.m. Eastern Time.
The conference call will be simulcast live on the Internet, and
can be accessed by logging on to www.pozen.com. A replay will be
available for seven days in the Investor Relations section of the
company's website. POZEN's fourth quarter and full-year results
release can be accessed in the News section at www.pozen.com.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has focused its efforts primarily on the development
of pharmaceutical products for the treatment of migraine. POZEN is
also exploring the development of product candidates in other
pain-related therapeutic areas. POZEN has development and commercial
alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The
company's common stock is traded on The Nasdaq Stock Market under the
symbol "POZN." For detailed company information, including copies of
this and other press releases, see POZEN's website: www.pozen.com.
CONTACT: POZEN Inc.
Bill Hodges 919-913-1030
Fran Barsky 919-913-1044
SOURCE: POZEN Inc.